GB0125127D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0125127D0
GB0125127D0 GBGB0125127.1A GB0125127A GB0125127D0 GB 0125127 D0 GB0125127 D0 GB 0125127D0 GB 0125127 A GB0125127 A GB 0125127A GB 0125127 D0 GB0125127 D0 GB 0125127D0
Authority
GB
United Kingdom
Prior art keywords
sup
sub
compounds
independently represent
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0125127.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0125127.1A priority Critical patent/GB0125127D0/en
Publication of GB0125127D0 publication Critical patent/GB0125127D0/en
Priority to ES02774728T priority patent/ES2238606T3/es
Priority to EP02774728A priority patent/EP1436007B1/en
Priority to AT02774728T priority patent/ATE291928T1/de
Priority to PCT/EP2002/011635 priority patent/WO2003035237A2/en
Priority to US10/492,606 priority patent/US7321059B2/en
Priority to JP2003537793A priority patent/JP4223954B2/ja
Priority to DE60203528T priority patent/DE60203528T2/de
Priority to AU2002340578A priority patent/AU2002340578A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/007—Organic compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/42—Ethers, e.g. polyglycol ethers of alcohols or phenols
    • C09K23/44—Ether carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
GBGB0125127.1A 2001-10-19 2001-10-19 Compounds Ceased GB0125127D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0125127.1A GB0125127D0 (en) 2001-10-19 2001-10-19 Compounds
ES02774728T ES2238606T3 (es) 2001-10-19 2002-10-17 Compuestos para uso como tensioactivos.
EP02774728A EP1436007B1 (en) 2001-10-19 2002-10-17 Compounds for use as surfactants
AT02774728T ATE291928T1 (de) 2001-10-19 2002-10-17 Oberflächenaktive verbindungen
PCT/EP2002/011635 WO2003035237A2 (en) 2001-10-19 2002-10-17 Compounds for use as surfactants
US10/492,606 US7321059B2 (en) 2001-10-19 2002-10-17 Compounds for use as surfactants
JP2003537793A JP4223954B2 (ja) 2001-10-19 2002-10-17 界面活性剤として使用するための化合物
DE60203528T DE60203528T2 (de) 2001-10-19 2002-10-17 Oberflächenaktive verbindungen
AU2002340578A AU2002340578A1 (en) 2001-10-19 2002-10-17 Compounds for use as surfactants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125127.1A GB0125127D0 (en) 2001-10-19 2001-10-19 Compounds

Publications (1)

Publication Number Publication Date
GB0125127D0 true GB0125127D0 (en) 2001-12-12

Family

ID=9924153

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0125127.1A Ceased GB0125127D0 (en) 2001-10-19 2001-10-19 Compounds

Country Status (9)

Country Link
US (1) US7321059B2 (https=)
EP (1) EP1436007B1 (https=)
JP (1) JP4223954B2 (https=)
AT (1) ATE291928T1 (https=)
AU (1) AU2002340578A1 (https=)
DE (1) DE60203528T2 (https=)
ES (1) ES2238606T3 (https=)
GB (1) GB0125127D0 (https=)
WO (1) WO2003035237A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470520A1 (en) 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
CA2474626A1 (en) 2002-02-13 2003-08-21 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US10640696B2 (en) 2017-08-15 2020-05-05 Saudi Arabian Oil Company Oil-based drilling fluids for high pressure and high temperature drilling operations
CN111032818A (zh) 2017-08-15 2020-04-17 沙特阿拉伯石油公司 油基钻井液的热稳定表面活性剂
US10988659B2 (en) 2017-08-15 2021-04-27 Saudi Arabian Oil Company Layered double hydroxides for oil-based drilling fluids
US10745606B2 (en) 2017-08-15 2020-08-18 Saudi Arabian Oil Company Oil-based drilling fluid compositions which include layered double hydroxides as rheology modifiers
US10793762B2 (en) 2017-08-15 2020-10-06 Saudi Arabian Oil Company Layered double hydroxides for oil-based drilling fluids
US10876039B2 (en) 2017-08-15 2020-12-29 Saudi Arabian Oil Company Thermally stable surfactants for oil based drilling fluids
US10676658B2 (en) 2017-08-15 2020-06-09 Saudi Arabian Oil Company Oil-based drilling fluids for high pressure and high temperature drilling operations
US10647903B2 (en) 2017-08-15 2020-05-12 Saudi Arabian Oil Company Oil-based drilling fluid compositions which include layered double hydroxides as rheology modifiers and amino amides as emulsifiers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
DE3903663C1 (https=) * 1989-02-08 1990-09-27 Huels Ag, 4370 Marl, De
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
AU650463B2 (en) 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
WO1992000061A1 (en) 1990-06-29 1992-01-09 Fisons Plc Pressurised aerosol compositions
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) 1994-09-28 1994-11-16 Glaxo Inc Medicaments
US6451287B1 (en) * 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
US7217409B2 (en) * 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
ES2293157T3 (es) 2001-08-03 2008-03-16 Glaxo Group Limited Compuestos tensioactivos y uso de los mismos.

Also Published As

Publication number Publication date
JP4223954B2 (ja) 2009-02-12
DE60203528T2 (de) 2006-05-11
ATE291928T1 (de) 2005-04-15
AU2002340578A1 (en) 2003-05-06
US7321059B2 (en) 2008-01-22
US20050048024A1 (en) 2005-03-03
WO2003035237A2 (en) 2003-05-01
DE60203528D1 (de) 2005-05-04
EP1436007A2 (en) 2004-07-14
WO2003035237A3 (en) 2003-08-14
ES2238606T3 (es) 2005-09-01
JP2005525300A (ja) 2005-08-25
EP1436007B1 (en) 2005-03-30

Similar Documents

Publication Publication Date Title
WO2002024623A3 (en) Novel alkanoic acid derivatives
BE2018C008I2 (https=)
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
AP1965A (en) Tropane derivatives useful in therapy.
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
TW200519088A (en) Aryl or heteroaryl amide compounds
WO2004071388A3 (en) Medicinal compounds
DE60124504D1 (de) Stabile emulsionszubereitungen
BRPI0411116A (pt) compostos fundidos que inibem receptor vanilóide de subtipo 1 - receptor (vr1)
GB0125127D0 (en) Compounds
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MX2023009045A (es) Derivados novedosos de pirimidin-2-il sulfonamida.
TW200612920A (en) Novel imidazolidine derivatives
TW200500806A (en) Resist composition and patterning process
SE0201658D0 (sv) Immediate release pharmaceutical formulation
EP1503721B8 (en) Hair care compositions containing phenolic styling agents
WO2001083457A3 (en) Benzimidazole-2-carbamates and their use in cancer treatment
EP1390343A4 (en) NOVEL RETINOID DERIVATIVES, METHODS FOR PREPARING THESE COMPOUNDS, AND ANTI-CANCER PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
MXPA04001049A (es) Compuestos surfactantes y usos de los mismos.
WO2000071538A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DE69827614D1 (de) Chinoxalindionen
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
GB0114699D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)